A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction

Table 3

Surface markers expression in both groups (SG and CG).

	CD29 (%)	CD31 (%)	CD34 (%)	CD45 (%)	CD73 (%)	CD90 (%)	CD105 (%)
Stem group
	7	7	5	7	7	7	7
Average	70,09	20,56	43,92	8,59	40,36	79,01	35,81
Median	80,54	0,74	18,64	1,6	39,78	81	35,52
Minimum	21,78	0	11	0	0	58,86	0
Maximum	94,9	65,92	92,3	32,5	88,88	96,66	89,78
SD	28,34	28,86	41,39	12,38	33,55	15,37	30,11
Control group
	4	4	4	4	4	4	4
Average	75,37	33,34	38,94	15,42	28,84	26,99	36,71
Median	73,88	31,78	45,23	0,3	28,3	24,09	33,88
Minimum	56,48	20,9	0	0	26,54	1,38	0
Maximum	97,24	48,9	65,3	61,08	32,2	58,38	79,08
SD	19,69	12,01	28,2	30,44	2,44	27,95	32,45
Total
	11	11	9	11	11	11	11
Average	72,01	25,2	41,71	11,07	36,17	60,09	36,14
Median	80,54	20,9	38,32	0,62	28,86	61,82	34,6
Minimum	21,78	0	0	0	0	1,38	0
Maximum	97,24	65,92	92,3	61,08	88,88	96,66	89,78
SD	24,6	24,18	34,09	19,54	26,66	32,64	29,33
	0,751	0,315	0,905	0,527	0,400	0,026	0,964

-Student for independent samples, Mann-Whitney.